glutathione and liver damage disease disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential Benefits of Glutathione

Ethics statement The studies involving humans were approved by Research Ethics Committee, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan

There were no statistically significant differences in clinical characteristics and baseline between the two groups (Table 1)

Treatment may involve dosage calculations, cycle length, delivery method, medication interactions, product quality concerns, and ongoing monitoring

This compensation does not influence the accuracy, neutrality, or integrity of the information presented

The Pharmacy Compounding Advisory Committee is advisory only it met July 2324, 2026 (docket FDA-2025-N-6895) to review nominations and make recommendations, and the FDA issues any final rule later, typically 618 months afterward